Virtual Issue: Alloantibodies

Published on 12/15/11

Guest Editors: Drs. Howard M. Gebel and Robert A. Bray

Read the newest Virtual Issue on Alloantibodies today!

Alloantibodies, especially those directed against HLA antigens, are a barrier to long-term solid organ allograft survival. Pretransplant, donor-directed alloantibodies represent a contraindication or, at least, a risk, for transplant, effectively limiting patient access to donor organs. Posttransplant, alloantibodies are associated with episodes of acute and chronic rejection as well as graft loss.

 Virtual Issue compiled online 15 December 2011

Bookmark and Share

Search the Site

Search

ScholarOne Manuscripts Log In

ScholarOne Manuscripts Log In
Enter User ID:

Enter Password:

Forgot your ScholarOne password?

Forgot your
ScholarOne password?
Enter your e-mail address to
receive an e-mail with your
account information.
 

Presenting the United States Organ Transplantation data report 2010




 
Download the free AJT mobile app



 Virtual Issues

  

KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Read The AJT Report